Skip to main content

Table 3 In vivo improvements achieved with scaffolds composed of the polysaccharides chitosan, alginate or hyaluronic acid

From: In vivo experience with natural scaffolds for myocardial infarction: the times they are a-changin’

Scaffold material

Cell lines and/or other components

MI model

Main results

References

Chitosan

Rat brown ATDSCs

Rat

Cell survival and retention↑, EF↑, FS↑, LV end-diastolic pressure↓, LV pressure change↑, infarct size↓, fibrosis↓, ATDSC to cardiac lineage differentiation↑, vessel density↑, endothelial and smooth muscle cell differentiation

[81]

 

Mouse ESCs

Rat

Infarct zone cell retention↑, ESC to cardiac differentiation, heart function↑, LV end-diastolic and end-systolic diameters↓, EF↑, FS↑, infarct size↓, wall thickness↑, complete chitosan degradation, microvessel density↑

[82]

 

Mouse nuclear-transferred ESCs or fertilization-derived mouse ESC

Rat

For both cell types: infarcted area covered↑, possible differentiation into CMs, smooth muscle cells and ECs, heart function↑, LV end-diastolic and end-systolic diameters↓, EF↑, FS↑, infarct size↓, wall thickness↑, complete chitosan degradation, neovascularization↑

[83]

 

bFGF

Rat

LV EF↑, LV FS↑, arteriole density↑, infarct size↓, fibrosis area↓

[84]

 

RoY peptide

Rat

Angiogenesis↑, ventricular wall thickness↑, fibrosis↓, infarct size↓, LV FS↑, LV EF↑

[85]

Chitosan+alginate

Rat MSCs

Rat

EF↑, LV function↑, angiogenesis↑

[77]

 

–

Rat

Angiogenesis↑, no inflammation exacerbation, apoptosis↓, presence of c-kit+ cells↑, proliferation↑, wall thickness↑, LV expansion↓, LV EF↑

[87]

Alginate

–

Rat

Absence of arrhythmias or thrombus formation, scaffold degraded, scar thickness↑, diastolic and systolic anterior wall thicknesses↑, LV end-diastolic and systolic dimensions↓, LV end-diastolic and systolic areas↓, cardiac dysfunction↓

[98]

 

–

Dog

End-systolic and end-diastolic wall thicknesses↑, LV end-diastolic and systolic volumes↓, end-systolic sphericity index↑, LV EF↑, functional mitral regurgitation↓, LV function↑

[99]

 

–

Pig

No arrhythmias or conduction blocks, no remote infarcts in other organs, LV enlargement↓, LV function↑, coronary blood flow not affected, scar thickness↑, anterior wall thickness↑

[100]

 

Rat fetal cardiac cells

Rat

Vascularization↑, formation of myofibers and gap junctions, preservation of LV dimensions and FS

[102]

 

Human ESCs or human embryonic bodies

Rat

FS↑, LV dilation, absence of inflammation, no cardiomyogenic differentiation, no cell retention

[103]

 

RGD peptide

Rat

FS↑, LV dimension↓, LV wall thickness↑, angiogenesis↑

[105]

 

RGD peptide+encapsulated MSCs (microbeads)

Rat

LV function↑, wall thickness preservation, LV internal dimensions preserved, infarct size↓, angiogenesis↑, high cell retention

[106]

 

Unmodified alginate; RGD or YIGSR peptide-modified alginate; or RGE peptide-modified alginate

Rat

Unmodified-alginate: scar thickness↑, attenuated LV systolic and diastolic dilatations, LV FS↑, fractional area change↑, LV expansion index↓ (compared with all peptide-modified alginates)

[107]

 

IGF/HGF (microbeads)

Rat

Scar thickness preservation, infarct expansion index↓, scar collagen accumulation↓, vascularization↑, apoptosis↓

[110]

 

–

Human

New York Heart Association functional class↑, Kansas City Cardiomyopathy Questionnaire score↑

[111]

Alginate+fibrin

–

Pig

LV posterior wall thickness↑, infarct expansion↓, extractable collagen↓

[115]

Alginate+Matrigel+omentum

Neonatal rat cardiac cells with SDF-1, IGF-1 and VEGF

Rat

Mechanical and electrical coupling, relative scar thickness↑, angiogenesis↑, infarct expansion index↓, FS and fractional area change preserved, LV end-diastolic and systolic dimensions↓

[117]

Alginate+polypyrrole

–

Rat

No inflammation, angiogenesis↑, myofibroblast population↑

[118]

Hyaluronic acid

Alone or with VEGF

Rat

Ventricle thickness↑, infarct size↓, apoptosis↓, vascularization↑, heart function↑

[121]

 

Rat BMMNCs

Rat

Apoptosis↓, inflammatory response↓, EF↑, ventricular dilatation↓, scar size↓, collagen content↓, angiogenesis↑, cell differentiation into ECs

[124]

 

Pig BMMNCs

Pig

LV EF↑, interventricular septum thickness↑, LV end-diastolic pressure and volume↓, contractility↑, scar size and length↓, fibrosis↓, high cell retention, neovascularization↑

[125]

 

Rat bone marrow MSCs (esterified hyaluronic acid)

Rat

Construct integration, vascularization↑, fibrosis↓

[126]

 

Pig bone marrow MSCs (esterified hyaluronic acid)

Pig

Inflammation↓, fibrosis↓, degeneration of cardiac cells↓

[127]

 

Hydroxyethyl methacrylate, SDF-1α, mouse bone marrow cells

Mouse

Cell homing in the myocardium↑

[128]

 

rTIMP-3

Pig

LV end-diastolic dimension↓, LV EF↑, wall stress↓, infarct expansion↓, wall thickness↑, LV end-diastolic volume preserved, myofibroblast number↑, collagen content↑

[130]

 

Gelin-S

Rat

LV EF↑, LV FS↑, neovascularization↑, collagen deposition↓

[131]

 

Methacrylic anhydride

Sheep

Regional wall thickness↑, infarcted area↓ (only for highly stiff scaffold)

[132]

 

Methacrylic anhydride or/and hydroxyethylmethacrylate

Sheep

Wall thickness↑, vascularization↑, inflammation↑, LV end-systolic volume↓ (only for highly stiff, stable scaffold)

[133]

Hyaluronic acid+gelatin

Human cardiosphere-derived cells

Mouse

Cardiac function↑, LV remodeling and abnormal heart morphology↓, viable tissue↑, wall thickness↑, cardiac and endothelial cellular differentiation, cellular engraftment↑, neovascularization↑, apoptosis↓

[134]

Hyaluronic acid+silk fibroin

Rat bone marrow MSCs

Rat

LV inner diameter↓, wall thickness↑, FS↑, inflammation↓, apoptosis↓, vascularization↑, α-MHC expression↑, paracrine factor secretion↑

[135]

Hyaluronic acid+chitosan+silk fibroin

–

Rat

LV inner diameter↓, wall thickness↑, LV FS↑, angiogenesis↑, paracrine factor expression↑

[136]

Hyaluronic acid+butyric and retinoic acids

Human placenta-derived MSCs

Pig

Scar size↓, infarct core zone↓, angiogenesis↑, fibrosis↓, end-systolic wall thickening and circumferential shortening↑, high homology with healthy myocardium

[137]

  1. ATDSC adipose tissue-derived stem cell, bFGF basic fibroblast growth factor, BMMNC bone marrow mononuclear cell, CM cardiomyocyte, EC endothelial cell, EF ejection fraction, ESC embryonic stem cell, FS fractional shortening, HGF hepatocyte growth factor, IGF insulin growth factor, LV left ventricle/left ventricular, MHC myosin heavy chain, MI myocardial infarction, MSC mesenchymal stem cell, rTIMP recombinant tissue inhibitor of matrix metalloproteinases, SDF stromal cell-derived factor, VEGF vascular endothelial growth factor